Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Share Price
Equities
002932
CNE1000033Q7
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.59 CNY | -1.61% | -2.05% | -14.71% |
Sales 2021 | 2.83B 391M 31.17B | Sales 2022 | 10.53B 1.45B 116B | Capitalization | 8.95B 1.23B 98.52B |
---|---|---|---|---|---|
Net income 2021 | 1.41B 195M 15.56B | Net income 2022 | 4.21B 581M 46.34B | EV / Sales 2021 | 2.09 x |
Net cash position 2021 | 1.85B 255M 20.33B | Net cash position 2022 | 4.3B 594M 47.41B | EV / Sales 2022 | 0.44 x |
P/E ratio 2021 |
4.99
x | P/E ratio 2022 |
2.1
x | Employees | 1,547 |
Yield 2021 |
6.08% | Yield 2022 |
9.08% | Free-Float | 49.87% |
1 day | -1.61% | ||
1 week | -2.05% | ||
Current month | -10.06% | ||
1 month | -9.43% | ||
3 months | -1.95% | ||
6 months | -14.75% | ||
Current year | -14.71% |
Managers | Title | Age | Since |
---|---|---|---|
Li Li Chen
CEO | Chief Executive Officer | 50 | 22/10/13 |
Guo Hui Zhou
DFI | Director of Finance/CFO | 40 | 17/08/21 |
Ying Wang
BRD | Director/Board Member | - | 30/10/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jin Cheng Xie
BRD | Director/Board Member | 63 | 25/11/21 |
Xian Wang Shi
BRD | Director/Board Member | 56 | 20/10/22 |
Li Li Chen
CEO | Chief Executive Officer | 50 | 22/10/13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 19.59 | -1.61% | 4,054,983 |
25/04/24 | 19.91 | -0.55% | 1,817,909 |
24/04/24 | 20.02 | -0.60% | 2,001,954 |
23/04/24 | 20.14 | +1.21% | 2,702,892 |
22/04/24 | 19.9 | -0.50% | 1,840,194 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-14.71% | 629M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.3B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B | |
-5.02% | 1.64B |
- Stock Market
- Equities
- 002932 Stock